Impact of routine transoesophageal echocardiography on safety, outcomes, and cost of pulmonary vein ablation: Inferences drawn from a decision analysis model

Europace

Volumn 12, Issue 11, 2010, Pages 1550-1557

  Gula, Lorne J ^a   Massel, David ^a   Redfearn, Damian P ^b   Krahn, Andrew D ^a   Yee, Raymond ^a   Klein, George J ^a   Skanes, Allan C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Atrial fibrillation; Cost effectiveness; Decision analysis; Pulmonary vein ablation; Transoesophageal echocardiography

Indexed keywords

ABLATION THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HIDDEN MARKOV MODEL; LUNG VEIN; PRIORITY JOURNAL; PULMONARY VEIN ABLATION; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL MODEL; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; COHORT STUDIES; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MARKOV CHAINS; PULMONARY VEINS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; STROKE; THROMBOSIS; TREATMENT OUTCOME;

EID: 78049502278     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq306     Document Type: Article

References (35)

1. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
2. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-81. (Pubitemid 34212617)
3. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
4. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5. (Pubitemid 40365469)
5. Redfearn DP. Transesophageal echocardiography prior to atrial fibrillation ablation: a Canadian atrial fibrillation and complex ablation alliance (CAFCAA) study. Can J Cardiol; 23 (Suppl. C): 167C.
6. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38.
7. Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:379-84.
8. Khan MN, Usmani A, Noor S, Elayi S, Ching CK, Di Biase L et al. Low incidence of left atrial or left atrial appendage thrombus in patients with paroxysmal atrial fibrillation and normal EF who present for pulmonary vein antrum isolation procedure. J Cardiovasc Electrophysiol 2008;19:356-8.
9. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009;10:383-8.
10. Rader VJ, Khumri TM, Idupulapati M, Stoner CN, Magalski A, Main ML. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation. J Am Soc Echocardiogr 2007;20:1181-5.
11. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ECAS expert consensus statement on catheter, surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007;9:335-79.
12. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ECAS expert Consensus Statement on catheter, surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007;4:816-61.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
14. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006;114:759-65.
15. Erdogan A, Carlsson J, Neumann T, Berkowitsch A, Neuzner J, Hamm CW et al. Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up. Pacing Clin Electrophysiol 2003;26:678-84.
16. Tada H, Naito S, Kurosaki K, Ueda M, Ito S, Shinbo G et al. Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. Circ J 2003;67:861-5.
17. Purerfellner H, Martinek M, Aichinger J, Nesser HJ, Kempen K, Janssen JP. Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation. Am Heart J 2004;148:318-25.
18. Goldberg A, Menen M, Mickelsen S, MacIndoe C, Binder M, Nawman R et al. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. J Interv Card Electrophysiol 2003;8:59-64.
19. Fryback DG, Lawrence WF, Martin PA, Klein R, Klein BE. Predicting quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997;17:1-9.
20. Calo L, Lamberti F, Loricchio ML, Castro A, Shpun S, Boggi A et al. Long-term follow-up of right atrial ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:37-43.
21. O'Brien JA, Patrick AR, Caro JJ. Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res 2003;3:7.
22. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR. Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:907-13. (Pubitemid 47342400)
23. Prystowsky EN, Themistoclakis S, Brachmann J et al. Anticoagulation issues. In Natale A, Raviele A (eds). Atrial Fibrillation Ablation-the State of the Art Based on the Venice Chart International Consensus Document. Malden, MA: Blackwell Futura; 2007. p41-50.
24. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
25. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005;96:935-41.
26. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-5.
27. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol 1995;25:1354-61.
28. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 2005;16:474-7.
29. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol 2006;17:1-7.
30. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WH, Gabriel RS et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009;54:2032-9.
31. Weinstein M, Fineberg H, Elstein A, Frazier HS, Neuhauser D, Neutra RR et al. Clinical Decision Analysis. Philadelphia, PA: W. B. Saunders; 1980.
32. Bell DE. Regret in decision making under uncertainty. Oper Res 1982;30:961-81.
33. Loomes G, Sugden R. Regret theory: an alternative theory of rational choice. Econ. J 1982;92:805-24.
34. Landman J. Regret and elation following action and inaction. J Pers Soc Psychol 1987;13:524-36.
35. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008;118:2498-505.